>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Scores Major Victory on Labor Epidural Supervision

Friday, January 21, 2011

CMS recently issued revised Interpretative Guidelines (IGs) to the Hospital Conditions of Participation that contain major victories for ASA’s regulatory lobbying efforts.  These guidelines revise major sections of the December 2009 CMS Hospital Interpretative Guidelines and are effective immediately.

CMS has removed language specifically exempting labor epidurals from the physician supervision requirements.  Hospitals are now required to “establish policies and procedures, based on nationally recognized guidelines, that address whether specific clinical situations involved anesthesia versus analgesia,” as well as, “the minimum qualifications and supervision requirements for each category of practitioner who is permitted to provide analgesia services.”  

When the 2009 IGs were released, ASA developed a comprehensive regulatory lobbying strategy, involving comment letters, meetings and discussions with appropriate CMS officials, with the goal of making substantive changes to the IGs.  ASA’s focus in all of its efforts was consistently on patient safety and quality of care coupled with emphasis on anesthesia as a continuum with no clear boundaries.  The strategy worked.  

Click here for updates on other victories ASA achieved in the new IGs.

Click here to read the CMS issued Revised Interpretive Guidelines.

Click here to read a memo from CMS on the Revised Interpretive Guidelines.

Click here to read FAQs released by CMS on the Revised Interpretive Guidelines.

 

 

« Back to Washington Alerts